P. Baluk

Molecular Biology · 2000–2007

A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 35 citations into it; #9,513 of 17,773 by trust here, #4,951 by citations
• Oncology — 18 citations into it
• Cancer Research — 17 citations into it; #761 of 1,780 by trust here, #665 by citations

Whom P. Baluk trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Rakesh K. Jain
2. H. Hashizume
3. Holger Gerhardt
4. Raghu Kalluri
5. D. McDonald
6. Peter Carmeliet
7. Lisa M. Coussens

Who trusts P. Baluk overall

1. Rakesh K. Jain
2. K. Alitalo
3. D. Hanahan
4. A. Armulik
5. Pengfei Lu
6. S. Carmichael
7. T. Tammela
8. G. Bergers
9. D. McDonald
10. H. Wiig

Papers from P. Baluk's perspective

Ordered by how strongly the researchers P. Baluk trusts endorse each paper. Same corpus, a different order for every researcher.

1. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
2. Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
3. Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
4. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
5. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. (American Journal of Pathology)
6. Pathology: Cancer cells compress intratumour vessels (Nature)
7. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
8. Endothelial-pericyte interactions in angiogenesis (Cell and Tissue Research)
9. Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis (Journal of Cell Biology)
10. Tumor angiogenesis (Advances in Cancer Research)

Their papers

• Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (2004) — 759 citations
• Openings between defective endothelial cells explain tumor vessel leakiness. (2000) — 1,654 citations
• Functionally specialized junctions between endothelial cells of lymphatic vessels (2007) — 958 citations
• Cellular abnormalities of blood vessels as targets in cancer. (2005) — 809 citations
• Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. (2005) — 618 citations
• Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. (2002) — 1,030 citations